BRENDA SMITH: Open Payments
NPI 1487677068 · SEMMES, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 31 payments from 9 companies in 2025. Trend: 2023 $313 · 2024 $621 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $157 |
| Novo Nordisk Inc | 6 | $117 |
| SANOFI-AVENTIS U.S. LLC | 5 | $116 |
| Corium, LLC | 3 | $61 |
| Lilly USA, LLC | 3 | $50 |
| Abbott Laboratories | 2 | $37 |
| Astellas Pharma US Inc | 2 | $37 |
| PFIZER INC. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: REPATHA, TZIELD, Wegovy, Azstarys, MOUNJARO, FREESTYLE LIBRE 3, Veozah, OTEZLA.
Industry payments across AL — which companies pay providers there.
